Aquestive Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2018 to Q3 2024.
  • Aquestive Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 91.1M shares, a 40.8% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 61.3M shares, a 25.7% increase from 2022.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48.7M shares, a 28% increase from 2021.
  • Aquestive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 38.1M shares, a 13.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 91.1M +26.4M +40.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 90.9M +33.6M +58.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 73.6M +18M +32.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 61.3M +12.5M +25.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 64.7M +11.3M +21.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 57.4M +11.9M +26.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 55.6M +14.2M +34.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 48.7M +10.7M +28% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 53.4M +14.2M +36.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 45.5M +8.4M +22.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 41.5M +5.9M +16.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 38.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 39.2M +5.61M +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 37.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 35.6M +1.99M +5.94% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 33.6M +8.59M +34.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q1 2020 33.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q3 2019 25M +1.39M +5.86% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-05
Q2 2019 25M +5.79M +30.2% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-06
Q3 2018 23.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 19.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.